The Oswaldo Cruz Institute (IOC/Fiocruz) presented, on June 12, 2012, an immunizer that proved to be safe and effective against schistosomiasis, a parasitic disease that threatens 800 million people in 70 countries. The first vaccine against the disease was approved in phase 1 of clinical trials. The study was led by the researcher of the IOC Miriam Tendler.

Check out the special coverage on the subject below:

Institute presents pioneering vaccine against schistosomiasis

Press conference announced the success of phase 1 clinical trials of the vaccine, which proved to be effective and safe against a parasitic disease that threatens 800 million people in 70 countries

Brazilian vaccine for schistosomiasis, unprecedented in the world, is approved in phase 1 of clinical trials

Immunizer proved effective and safe against parasitic disease that threatens 800 million people in 70 countries

Sm14 vaccine history

Find out about the development trajectory of the world's first vaccine against schistosomiasis

Learn more about schistosomiasis

Second most socioeconomically devastating parasitic disease, infects more than 200 million people worldwide